Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01931826Not ApplicableCompleted

Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery

Role: lead

NCT01777204Unknown

Gastrointestinal Transit and Motility in Renal Transplant Recipients

Role: lead

NCT01260077Completed

Steady State Vestibular Evoked Myogenic Potentials

Role: lead

NCT01132092Completed

The Normal Standard of Brainstem Auditory Evoked Potential in Adults Using a New Device

Role: lead

NCT01132105Completed

Vestibular Evoked Myogenic Potential: A New Device Propose

Role: lead

All 5 trials loaded